ConductScience.org, home

Gene · 4100

MAGEA1: MAGE family member A1

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MAGEA1: MAGE family member A1. Genes, record 4100. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4100

On this page

Gene

Symbol
MAGEA1
HGNC
Name
MAGE family member A1
HGNC
NCBI Gene ID
4100
NCBI Gene
HGNC ID
HGNC:6796
HGNC
Ensembl
ENSG00000198681
NCBI Gene
Aliases
CT1.1, MAGE1, MGC9326
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P43355Melanoma-associated antigen 13092Ensembl, GeneID, HGNC

Source UniProt

Patents161

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4641201 A22025-10-297278P43355Espacenet
JP 2025160297 A2025-10-22120P43355Espacenet
JP 2025533851 A2025-10-0915P43355Espacenet
WO 2025146286 A12025-07-1031P43355Espacenet
JP 2025517969 A2025-06-127278P43355Espacenet
JP 2025084910 A2025-06-0321P43355Espacenet
JP 2025516264 A2025-05-2740P43355Espacenet
US 12280021 B22025-04-22117P43355Espacenet
JP 2025062611 A2025-04-1490P43355Espacenet
US 12269793 B22025-04-08117P43355Espacenet

1 to 10 of 161

See all 161 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants735

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMAGEA1 papersNewest fiscal year
P30CA016672Cancer Center Support Grant132025
P30CA016056Roswell Park Cancer Center Support Grant122025
P30CA044579University of Virginia Cancer Center Support Grant112025
P30CA008748Cancer Center Support Grant82025
ZIABC010985Gene therapy of cancer72025
ZIABC010984Adoptive Cell Transfer Immunotherapy of Cancer52025
P30CA006973Regional Oncology Research Center42025
P30CA016058Cancer Center Support Grant42025
T32CA163177Postdoctoral Training Grant for MDs in Surgical Oncology Research42025
ZIAAI000860Deciphering CTCF code in human host and viral epigenomes42025

1 to 10 of 735Source NIH's project files

See all 735 nih grants

Papers1,534

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Comparative diagnostic value of a blood-based three-gene DNA methylation assay and a seven-autoantibody panel for differentiating pulmonary nodules.J Liq Biopsy202642825038PubTator, text miningPubMed
Targeting the β2-adrenergic receptor suppresses melanoma progression by disrupting the PKA-SOX10-MAGEA1 oncogenic axis.Biochem Pharmacol202642604673PubTator, text miningPubMed
The Construction and Preclinical Evaluation of Antitumor Activity of a Novel MIgG-OXA ADC in Lung Adenocarcinoma.Oncol Res202642500564PubTator, text miningPubMed
Hypomethylation of FAM83A in lung adenocarcinoma mirrors an epigenetic signature of airway cell differentiation states.Discov Oncol202642251611PubTator, text miningPubMed
Molecular subtyping and prognostic model construction based on endosome-related genes in colorectal cancer.J Gastrointest Oncol202642169884PubTator, text miningPubMed
DNA methylation as a predictor of pituitary neuroendocrine tumour behaviour: A systematic review.J Neuroendocrinol202641866138PubTator, text miningPubMed
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering.Science202641855322PubTator, text miningPubMed
The early diagnostic value of lung cancer autoantibodies and tumor markers in lung cancer.Clin Transl Oncol202641824177PubTator, text miningPubMed
Cross-Species Upregulation of MAGED2 in Liver Cancer Suggests a Role in Obesity-Driven Tumor Progression.Curr Issues Mol Biol202641751403PubTator, text miningPubMed
Therapeutic Strategies for Hepatocellular Carcinoma: Current Advances and Future Perspectives.Vaccines (Basel)202641746109PubTator, text miningPubMed

1 to 10 of 1,534

See all 1,534 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/4100

GET https://conductscience.org/api/genes/v1/4100/patents?page=2